| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Puma Biotechnology Inc (NASDAQ: PBYI)
PBYI Technical Analysis
4
| As on 9th Jun 2023 PBYI STOCK Price closed @ 3.38 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.71 & Strong Buy for SHORT-TERM with Stoploss of 2.62 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PBYISTOCK Price
| Open | 3.46 | Change | Price | % |
| High | 3.56 | 1 Day | -0.13 | -3.70 |
| Low | 3.36 | 1 Week | 0.19 | 5.96 |
| Close | 3.38 | 1 Month | 0.66 | 24.26 |
| Volume | 201826 | 1 Year | -0.20 | -5.59 |
| 52 Week High 5.08 | 52 Week Low 1.64 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PBYI Daily Charts |
PBYI Intraday Charts |
Whats New @ Bazaartrend |
PBYI Free Analysis |
|
|
PBYI Important Levels Intraday
| RESISTANCE | 3.77 |
| RESISTANCE | 3.64 |
| RESISTANCE | 3.57 |
| RESISTANCE | 3.49 |
| SUPPORT | 3.27 |
| SUPPORT | 3.19 |
| SUPPORT | 3.12 |
| SUPPORT | 2.99 |
PBYI Forecast May 2024
| 4th UP Forecast | 5.29 |
| 3rd UP Forecast | 4.68 |
| 2nd UP Forecast | 4.3 |
| 1st UP Forecast | 3.92 |
| 1st DOWN Forecast | 2.84 |
| 2nd DOWN Forecast | 2.46 |
| 3rd DOWN Forecast | 2.08 |
| 4th DOWN Forecast | 1.47 |
PBYI Weekly Forecast
| 4th UP Forecast | 4.36 |
| 3rd UP Forecast | 4.05 |
| 2nd UP Forecast | 3.85 |
| 1st UP Forecast | 3.66 |
| 1st DOWN Forecast | 3.10 |
| 2nd DOWN Forecast | 2.91 |
| 3rd DOWN Forecast | 2.71 |
| 4th DOWN Forecast | 2.40 |
PBYI Forecast2024
| 4th UP Forecast | 10.24 |
| 3rd UP Forecast | 8.04 |
| 2nd UP Forecast | 6.68 |
| 1st UP Forecast | 5.32 |
| 1st DOWN Forecast | 1.44 |
| 2nd DOWN Forecast | 0.08 |
| 3rd DOWN Forecast | -1.28 |
| 4th DOWN Forecast | -3.48 |
Puma Biotechnology Inc ( NASDAQ USA Symbol : PBYI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PBYI Business Profile
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California. Address: 10880 Wilshire Boulevard, Los Angeles, CA, United States, 90024
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service